Response to: "A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial"

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 21; no. 1; p. 65
Main Authors Madison, Annelise, Andersen, Barbara L, Ajam, Ali
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.02.2019
BioMed Central
BMC
Subjects
Antirheumatic Agents
Arthritis
Arthritis, Rheumatoid
Care and treatment
Certolizumab Pegol
Clinical trials
Comorbidity
Depression (Mood disorder)
Genetic aspects
Health aspects
Humans
Identification and classification
Letter
Phenotype
Phenotypes
Rheumatoid arthritis
Rheumatoid factor
Testing
United States
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1478-6362
1478-6354
1478-6362
DOI:10.1186/s13075-019-1848-4